301130SZSE

Announcement on the Revision of the Company Articles and the Formulation of Certain Company Systems

West Point Pharmaceuticals Co., Ltd.·March 20, 2026

✨ AI Summary

On March 20, 2026, the Board of Directors of Xidian Pharmaceutical Co., Ltd. approved proposals to revise the Articles of Association and certain internal systems. These revisions aim to enhance corporate governance and align with strategic development needs. The changes will be submitted for shareholder approval at the upcoming extraordinary general meeting. Relevant documents will be disclosed on the company's website.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Announcement on the Revision of the Company Articles and the Formulation of Certain Company Systems

Xidian Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") held the 15th meeting of the 8th Board of Directors on March 20, 2026, where it reviewed and approved the proposals on the revision of the Articles of Association and the formulation of certain internal systems. These matters are subject to approval by the shareholders' meeting. The relevant information is announced as follows:

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.